Sign inGet started

Ullman Anders

Insider CIK 1836816 · VRNA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-08200,000— $00SEC↗
VRNA Verona Pharma plc M Exercise deriv2025-10-072025-10-0872,000— $00SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-0896,000— $00SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-08240,000— $00SEC↗
VRNA Verona Pharma plc D To issuer deriv2025-10-072025-10-0864,000— $00SEC↗
VRNA Verona Pharma plc D To issuer2025-10-072025-10-0872,000— $00SEC↗
VRNA Verona Pharma plc M Exercise2025-10-072025-10-0872,000— $072,000SEC↗
VRNA Verona Pharma plc D To issuer2025-10-072025-10-08358,856— $00SEC↗
VRNA Verona Pharma plc M Exercise deriv2025-08-012025-08-0524,000— $072,000SEC↗
VRNA Verona Pharma plc M Exercise2025-08-012025-08-0524,000— $0358,856SEC↗
VRNA Verona Pharma plc A Award deriv2025-04-252025-04-2996,000— $096,000SEC↗
VRNA Verona Pharma plc A Award deriv2024-04-292024-04-30240,000— $0240,000SEC↗
VRNA Verona Pharma plc A Award deriv2023-04-282023-04-2896,000— $096,000SEC↗
VRNA Verona Pharma plc A Award deriv2022-04-282022-04-29200,000— $0200,000SEC↗
VRNA Verona Pharma plc A Award deriv2021-08-092021-08-1064,000— $064,000SEC↗
VRNA Verona Pharma plc S Sale2021-05-042021-05-0512,056$0.84 $10.1K334,856SEC↗
VRNA Verona Pharma plc S Sale2021-02-012021-02-0310,800$0.99 $10.7K346,912SEC↗